Regional and national burden and aetiologies of non-COVID lower respiratory infections in Latin America and the Caribbean, 1990–2023: a secondary analysis of the global burden of disease study 2023
Background Lower respiratory tract infections (LRTIs) remain a leading cause of morbidity and mortality worldwide, disproportionately affecting low- and middle-income regions. Reliable, up-to-date burden estimates are needed to inform public health strategies in Latin America and the Caribbean, where prevention and management strategies remain heterogeneous. We aimed to characterise temporal and geographical patterns in LRTI mortality, incidence, disability-adjusted life-years (DALYs), and aetiology across the region from 1990 to 2023. Methods We analysed secondary, modelled estimates of mortality, incidence, and DALYs attributable to LRTIs in Latin America and the Caribbean from 1990 to 2023, extracted from the GBD 2023 Results Tool and produced following the standardised GBD protocol coordinated by the Institute for Health Metrics and Evaluation (IHME). Findings In Latin America and the Caribbean, LRTI mortality declined in most countries between 1990 and 2023, with the steepest reductions among children younger than five years (e.g., Brazil ARC −6·16, 95% UI −6·61 to −5·71). All-age mortality rose in some countries, but age-standardised rates showed that these increases reflected population ageing rather than rising age-specific risk. Following a sustained pre-pandemic decline, incidence showed and overall upward direction in the post-pandemic period across age groups, although the magnitude and statistical relevance of these changes varied by age and country, with the largest increase observed among children in Suriname (ARC +8·84, 95% UI +2·80 to +14·95). Streptococcus pneumoniae remained the leading cause of LRTI mortality in 2023 (7·68 per 100,000, 95% UI 7·11–8·24; ARC −2·70, 95% UI −2·96 to −2·45). Interpretation LRTIs remain a major cause of death in the region, with substantial progress among children but persistent burden among older adults, driven by population ageing, and evidence of a post-pandemic increase in incidence. There is a great importance of combining clinical interventions with broader public health strategies addressing vaccination coverage, antimicrobial-resistance surveillance, nutrition, housing, and access to primary care, particularly in populations that have experienced less favourable trends. Funding Wellcome Trust (303666/Z/23/Z); UK International Development (301542–403); the Gates Foundation (INV–063472) and Universidad de La Sabana (MED–289–2020).
Authors
- Vincent Mougin (ORCID: https://orcid.org/0009-0006-7973-3435)
- Cristian C. Serrano-Mayorga (ORCID: https://orcid.org/0000-0001-8344-0535)
- Eve E Wool (ORCID: https://orcid.org/0000-0003-2107-4538)
- Natalia Sanabria-Herrera (ORCID: https://orcid.org/0009-0003-3790-4740)
- Luis Felipe Reyes (ORCID: https://orcid.org/0000-0003-1172-6539)
- Juan Sebastián Hurtado (ORCID: https://orcid.org/0009-0003-6445-8571)
- Valeria Aguirre-Gutierrez (ORCID: https://orcid.org/0009-0003-5846-8781)
- Luis Fernanda Martinez (ORCID: https://orcid.org/0009-0007-4295-168X)
- Mohsen Naghavi
- Daniel C. Tellez-Barros
Institutions
- Universidad de La Sabana (CO)
- Institute for Health Metrics and Evaluation (US)
- University of Oxford (GB)
- International Severe Acute Respiratory and Emerging Infection Consortium (GB)
Publication Details
- Journal
- The Lancet Regional Health - Americas
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1016/j.lana.2026.101686
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bill and Melinda Gates Foundation
- Wellcome Trust
- Department for International Development
- Universidad de La Sabana